Year-end Sale % OFF 
Abstract
Twenty-five resveratrol derivatives were synthesized, among which eight compounds have not yet been reported. The target compounds were evaluated for thrombin inhibitory activity in vitro (IC50). The results showed that four compounds displayed a better thrombin inhibitory activity with IC50 values from 10.43 to 18.31 μM, better than resveratrol (25.87 μM). The R3 position of resveratrol was modified by heterocyclic rings containing oxygen and sulfur, which could increase the anticoagulant activity of resveratrol.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
